Hepatitis B Vaccine (Recombinant) Completed Phase 1 Trials for Viral Hepatitis B Prevention

clinicaltrials.gov IdentifierTitleDrugs
NCT00426712Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients
NCT00699231Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients
NCT02057263The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults